Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0000950103-23-001812
Filing Date
2023-02-02
Accepted
2023-02-02 17:01:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM 424B7 dp188344_424b7.htm 424B7 665398
2 EXHIBIT 107.1 dp188344_exfilingfees.htm EX-FILING FEES 22826
3 GRAPHIC image_005.jpg GRAPHIC 5297
4 GRAPHIC image_006.jpg GRAPHIC 30346
5 GRAPHIC image_007.jpg GRAPHIC 4194
6 GRAPHIC image_008.jpg GRAPHIC 5278
  Complete submission text file 0000950103-23-001812.txt   751890
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-256807 | Film No.: 23582020
SIC: 2834 Pharmaceutical Preparations